Page last updated: 2024-11-07

b 4162

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

B 4162: bradykinin inhibitor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID123973
MeSH IDM0152151

Synonyms (22)

Synonym
gtpl675
[d-arg0,hyp2,3,thi5,8,d-phe7]bradykinin
b 4162
arg(0)-(hyp(3)-thi(5,8)-d-phe(7))-bk
b 4881
arg-3-hyp-5-(2-thi-ala)-7-phe-8-(2-thi-ala)-bradykinin
bradykinin, arginyl-hydroxyproly(3)-(2-thienylalanyl)(5)-phenylalanyl(7)-(2-thienylalanine)(8)-
npc-349
d-arg-(hyp(3),thi(5,8),d-phe(7))bradykinin
b-4881 ,
(arg(0)-hyp(3)-thi(5)-phe(7)-thi(8))bradykinin
bradykinin, arg-hyp(3)-gly-(2-thi-ala)(5)-phe(7)-(2-thi-ala)(8)-
b-4162 ,
arg-3-hyp-5,8-thi-7-phe-bradykinin
l-arginine, n2-(n-(n-(n-(n-(n-(1-(1-(n2-d-arginyl-l-arginyl)-l-prolyl)-trans-4-hydroxy-l-prolyl)glycyl)-3-(2-thienyl)-l-alanyl)-l-seryl)-d-phenylalanyl)-3-(2-thienyl)-l-alanyl)-
arginyl-arginyl-prolyl-hydroxyprolyl-glycl-(2-thienyl)alanyl-seryl-phenylalanyl-(2-thienyl)alanyl-arginine
b-6572 ,
npc 349
b 6572
bradykinin, d-arg(0)-hyp(3)-d-phe(7)-thi(5,8)
103412-42-6
Q27088024

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" histamine, characterized by a left shift in the dose-response curve."( Effects of bradykinin receptor antagonists on antigen-induced respiratory distress, airway hyperresponsiveness and eosinophilia in guinea-pigs.
Farmer, SG; Meeker, SA; Page, CP; Seeds, EA; Wilkins, DE, 1992
)
0.28
" In other rats kept on a low or a high sodium intake, dose-response curves to exogenous bradykinin were established."( Influence of bradykinin on blood pressure regulation of spontaneously hypertensive rats maintained on different sodium intakes.
Aubert, JF; Brunner, HR; Nussberger, J; Stewart, JM; Vavrek, R; Waeber, B, 1987
)
0.27
" In alpha-chloralose-anesthetized rats, tachyphylaxis to pericardial administration of 1 microgram BK occurred at 5 and 15, but not at 30 min dosing intervals."( Use of an indwelling catheter for examining cardiovascular responses to pericardial administration of bradykinin in rat.
Gebhart, GF; Gutterman, DD; McDermott, DA; Meller, ST, 1995
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1346510Mouse B2 receptor (Bradykinin receptors)1994Molecular pharmacology, Jan, Volume: 45, Issue:1
Differential pharmacology of cloned human and mouse B2 bradykinin receptors.
AID1346473Human B2 receptor (Bradykinin receptors)1994Molecular pharmacology, Jan, Volume: 45, Issue:1
Differential pharmacology of cloned human and mouse B2 bradykinin receptors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (49)

TimeframeStudies, This Drug (%)All Drugs %
pre-199016 (32.65)18.7374
1990's31 (63.27)18.2507
2000's2 (4.08)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.41 (24.57)
Research Supply Index3.95 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.00%)5.53%
Reviews1 (2.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other48 (96.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]